Suppr超能文献

口服氨基酸补充剂后生长激素增加:一项健康受试者随机、安慰剂对照、双盲、交叉研究的结果。

Increased Human Growth Hormone After Oral Consumption of an Amino Acid Supplement: Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Study in Healthy Subjects.

机构信息

Pennington Biomedical Research Center, LSU System, Baton Rouge, LA.

The Charles Perkins Centre and School of Life and Environmental Sciences, University of Sydney, Sydney, Australia; and.

出版信息

Am J Ther. 2020 Jul/Aug;27(4):e333-e337. doi: 10.1097/MJT.0000000000000893.

Abstract

BACKGROUND

Human growth hormone (hGH) is best known for influencing bone and muscle growth, as well as body composition, but the use of recombinant hGH is controversial. Amino acids are a potentially safer alternative; however, preliminary investigations of the effects of oral amino acids on hGH release have been inconclusive. Therefore, we tested the effects of a novel blend of amino acids optimized to increase hGH release.

STUDY QUESTION

Does an investigational amino acid supplement affect hGH release?

STUDY DESIGN

This was a randomized, placebo-controlled, double-blind, crossover study that included 16 (12 men, 4 women; age 32 ± 14 years; body mass index 26.4 ± 5.0 kg/m) healthy participants. All participants received both placebo and the amino acid supplement after an overnight fast and completed all study visits. Treatment order was randomized, and each treatment was separated by a 1-week washout period.

MEASURES AND OUTCOMES

The primary outcomes were the percent change in hGH from baseline to 120 minutes and the area under the curve of hGH over baseline. Serum hGH was measured using enzyme-linked immunosorbent assay at baseline and 15, 30, 60, 90, and 120 minutes.

RESULTS

At 120 minutes, hGH levels increased by 682% (8-fold) from baseline and were significantly higher than placebo (P = 0.01). In addition, a significantly higher mean area under the curve was observed for the amino acid supplement compared with the placebo [20.4 (95% confidence interval, 19.9-21.0 ng/mL) vs. 19.7 (95% confidence interval, 18.7-20.6 ng/mL); P = 0.04].

CONCLUSIONS

These results show that a single dose of the oral amino acid supplement was sufficient to significantly increase hGH levels in healthy adult men and women. CLINICAL TRIAL REGISTRY:: clinicaltrials.gov NCT01540773.

摘要

背景

人体生长激素(hGH)最常被用于影响骨骼和肌肉生长以及身体成分,但重组 hGH 的使用存在争议。氨基酸是一种潜在更安全的替代品;然而,口服氨基酸对 hGH 释放影响的初步研究尚无定论。因此,我们测试了一种新型优化以增加 hGH 释放的氨基酸混合物的效果。

研究问题

一种研究性氨基酸补充剂是否会影响 hGH 释放?

研究设计

这是一项随机、安慰剂对照、双盲、交叉研究,包括 16 名(12 名男性,4 名女性;年龄 32 ± 14 岁;体重指数 26.4 ± 5.0 kg/m)健康参与者。所有参与者均在禁食过夜后接受安慰剂和氨基酸补充剂,并完成所有研究访视。治疗顺序随机,每种治疗方法之间间隔 1 周洗脱期。

测量和结果

主要结局是 hGH 从基线到 120 分钟的百分比变化和 hGH 基线以上的曲线下面积。使用酶联免疫吸附试验在基线和 15、30、60、90 和 120 分钟测量血清 hGH。

结果

120 分钟时,hGH 水平从基线增加 682%(8 倍),明显高于安慰剂(P = 0.01)。此外,与安慰剂相比,氨基酸补充剂的平均曲线下面积显著更高[20.4(95%置信区间,19.9-21.0 ng/mL)与 19.7(95%置信区间,18.7-20.6 ng/mL);P = 0.04]。

结论

这些结果表明,单次口服氨基酸补充剂足以显著增加健康成年男女的 hGH 水平。临床试验注册号:clinicaltrials.gov NCT01540773。

相似文献

2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Treatments for seizures in catamenial (menstrual-related) epilepsy.
Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3.
9
Physostigmine for Alzheimer's disease.
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
10
Recombinant growth hormone in children and adolescents with Turner syndrome.
Cochrane Database Syst Rev. 2003(3):CD003887. doi: 10.1002/14651858.CD003887.

本文引用的文献

1
Growth hormone (GH) enhances anaerobic capacity: impact on physical function and quality of life in adults with GH deficiency.
Clin Endocrinol (Oxf). 2016 Oct;85(4):660-8. doi: 10.1111/cen.13147. Epub 2016 Jul 22.
2
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years.
J Endocrinol. 2015 Aug;226(2):T123-40. doi: 10.1530/JOE-15-0120. Epub 2015 Jun 3.
3
Impairment of anaerobic capacity in adults with growth hormone deficiency.
J Clin Endocrinol Metab. 2015 May;100(5):1811-8. doi: 10.1210/jc.2015-1006. Epub 2015 Feb 19.
4
Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.
J Clin Endocrinol Metab. 2014 Mar;99(3):852-60. doi: 10.1210/jc.2013-3921. Epub 2014 Jan 1.
5
Clinical practice. Short stature in childhood--challenges and choices.
N Engl J Med. 2013 Mar 28;368(13):1220-8. doi: 10.1056/NEJMcp1213178.
6
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609. doi: 10.1210/jc.2011-0179.
7
Effects of an oral growth hormone secretagogue in older adults.
J Clin Endocrinol Metab. 2009 Apr;94(4):1198-206. doi: 10.1210/jc.2008-0632. Epub 2009 Jan 27.
9
Growth hormone assays: current methodologies and their limitations.
Pituitary. 2007;10(2):115-9. doi: 10.1007/s11102-007-0030-1.
10
Growth hormone pulsatility profile characteristics following acute heavy resistance exercise.
J Appl Physiol (1985). 2001 Jul;91(1):163-72. doi: 10.1152/jappl.2001.91.1.163.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验